Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Stock picking requires research and discipline; assess whether your time, resources, and goals justify active selection over passive options.
17,093 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Tech stocks wobbled Friday as yields spiked, triggering a risk-off pullback. This piece lays out where to position wh...
Discipline beats flashier tactics. A written plan plus automatic investing is the real wealth management secret that ...
Bank of America and Ford recently flashed bullish signals after their golden crosses, but retirees must weigh income ...
A rising pushback against data centers is reshaping the debate over AI infrastructure. This article breaks down what ...
As IPO chatter heats up in 2026, SpaceX faces a pivotal moment. The CFO’s quiet leadership could define the deal, unl...
Former first lady Michelle Obama offers a fresh take on her Go High motto, portraying it as a guardrail for disciplin...
A landmark massive multi-billion-dollar industry merger is reshaping how investors view McCormick, nudging it from a ...
As markets enter the midyear phase of 2026, three proven compounders highlight why patient investing still works. App...
Super Micro Computer led the AI server rally, rising roughly 9-10% as peers lag, signaling renewed momentum in data-c...
NVIDIA CEO Jensen Huang challenges the AI jobs doomsayers narrative as the company posts blockbuster revenue driven b...